United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Aug 6, 2026 · Filed Aug 6, 2026

On Aug 6, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$517.05 for US$4.29M under a trading plan, leaving 45,172 shares. Filed Aug 6, 2026 (Form 4).

Sold
8,300 shares
Price
US$517.05 average (US$512.92 to US$522.40)
Value
US$4.29M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2026Common StockOption exercise8,300US$146.0353,472Direct
Aug 6, 2026Common StockSale760US$512.9252,712Direct
Aug 6, 2026Common StockSale1,795US$514.8250,917Direct
Aug 6, 2026Common StockSale1,360US$515.9349,557Direct
Aug 6, 2026Common StockSale1,617US$516.9347,940Direct
Aug 6, 2026Common StockSale780US$517.9447,160Direct
Aug 6, 2026Common StockSale360US$518.8246,800Direct
Aug 6, 2026Common StockSale1,308US$521.5045,492Direct
Aug 6, 2026Common StockSale320US$522.4045,172Direct

Source

View original at SEC

Related